Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 273

1.

Detection of an Immunogenic HERV-E Envelope with Selective Expression in Clear Cell Kidney Cancer.

Cherkasova E, Scrivani C, Doh S, Weisman Q, Takahashi Y, Harashima N, Yokoyama H, Srinivasan R, Linehan WM, Lerman MI, Childs RW.

Cancer Res. 2016 Apr 15;76(8):2177-85. doi: 10.1158/0008-5472.CAN-15-3139. Epub 2016 Feb 9.

2.

Tumor Suppressor Function of the SEMA3B Gene in Human Lung and Renal Cancers.

Loginov VI, Dmitriev AA, Senchenko VN, Pronina IV, Khodyrev DS, Kudryavtseva AV, Krasnov GS, Gerashchenko GV, Chashchina LI, Kazubskaya TP, Kondratieva TT, Lerman MI, Angeloni D, Braga EA, Kashuba VI.

PLoS One. 2015 May 11;10(5):e0123369. doi: 10.1371/journal.pone.0123369. eCollection 2015.

3.

Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.

Senchenko VN, Kisseljova NP, Ivanova TA, Dmitriev AA, Krasnov GS, Kudryavtseva AV, Panasenko GV, Tsitrin EB, Lerman MI, Kisseljov FL, Kashuba VI, Zabarovsky ER.

Epigenetics. 2013 Apr;8(4):409-20. doi: 10.4161/epi.24233. Epub 2013 Mar 11.

4.

Genetic and epigenetic analysis of non-small cell lung cancer with NotI-microarrays.

Dmitriev AA, Kashuba VI, Haraldson K, Senchenko VN, Pavlova TV, Kudryavtseva AV, Anedchenko EA, Krasnov GS, Pronina IV, Loginov VI, Kondratieva TT, Kazubskaya TP, Braga EA, Yenamandra SP, Ignatjev I, Ernberg I, Klein G, Lerman MI, Zabarovsky ER.

Epigenetics. 2012 May;7(5):502-13. doi: 10.4161/epi.19801. Epub 2012 May 1.

PMID:
22491060
5.

LRRC3B gene is frequently epigenetically inactivated in several epithelial malignancies and inhibits cell growth and replication.

Haraldson K, Kashuba VI, Dmitriev AA, Senchenko VN, Kudryavtseva AV, Pavlova TV, Braga EA, Pronina IV, Kondratov AG, Rynditch AV, Lerman MI, Zabarovsky ER.

Biochimie. 2012 May;94(5):1151-7. doi: 10.1016/j.biochi.2012.01.019. Epub 2012 Feb 2.

PMID:
22321817
6.

Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.

Cherkasova E, Malinzak E, Rao S, Takahashi Y, Senchenko VN, Kudryavtseva AV, Nickerson ML, Merino M, Hong JA, Schrump DS, Srinivasan R, Linehan WM, Tian X, Lerman MI, Childs RW.

Oncogene. 2011 Nov 24;30(47):4697-706. doi: 10.1038/onc.2011.179. Epub 2011 May 23.

7.

A novel MECA3 region in human 3p21.3 harboring putative tumor suppressor genes and oncogenes.

Braga E, Loginov W, Khodyrev D, Pronina I, Kazubskaya T, Bogatyrova O, Kashuba VI, Senchenko VN, Klein G, Lerman MI, Kisselev LL, Zabarovsky ER.

Exp Oncol. 2011 Mar;33(1):33-41.

PMID:
21423093
8.

Differential expression of CHL1 gene during development of major human cancers.

Senchenko VN, Krasnov GS, Dmitriev AA, Kudryavtseva AV, Anedchenko EA, Braga EA, Pronina IV, Kondratieva TT, Ivanov SV, Zabarovsky ER, Lerman MI.

PLoS One. 2011 Mar 7;6(3):e15612. doi: 10.1371/journal.pone.0015612.

9.

Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer.

Senchenko VN, Anedchenko EA, Kondratieva TT, Krasnov GS, Dmitriev AA, Zabarovska VI, Pavlova TV, Kashuba VI, Lerman MI, Zabarovsky ER.

BMC Cancer. 2010 Mar 1;10:75. doi: 10.1186/1471-2407-10-75.

10.

High mutability of the tumor suppressor genes RASSF1 and RBSP3 (CTDSPL) in cancer.

Kashuba VI, Pavlova TV, Grigorieva EV, Kutsenko A, Yenamandra SP, Li J, Wang F, Protopopov AI, Zabarovska VI, Senchenko V, Haraldson K, Eshchenko T, Kobliakova J, Vorontsova O, Kuzmin I, Braga E, Blinov VM, Kisselev LL, Zeng YX, Ernberg I, Lerman MI, Klein G, Zabarovsky ER.

PLoS One. 2009 May 29;4(5):e5231. doi: 10.1371/journal.pone.0005231.

11.

Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development.

Liao SY, Lerman MI, Stanbridge EJ.

BMC Dev Biol. 2009 Mar 16;9:22. doi: 10.1186/1471-213X-9-22.

12.

HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro.

Wang F, Grigorieva EV, Li J, Senchenko VN, Pavlova TV, Anedchenko EA, Kudryavtseva AV, Tsimanis A, Angeloni D, Lerman MI, Kashuba VI, Klein G, Zabarovsky ER.

PLoS One. 2008 Aug 22;3(8):e3031. doi: 10.1371/journal.pone.0003031.

13.

Two novel VHL targets, TGFBI (BIGH3) and its transactivator KLF10, are up-regulated in renal clear cell carcinoma and other tumors.

Ivanov SV, Ivanova AV, Salnikow K, Timofeeva O, Subramaniam M, Lerman MI.

Biochem Biophys Res Commun. 2008 Jun 13;370(4):536-40. doi: 10.1016/j.bbrc.2008.03.066. Epub 2008 Mar 24.

14.

Regression of human kidney cancer following allogeneic stem cell transplantation is associated with recognition of an HERV-E antigen by T cells.

Takahashi Y, Harashima N, Kajigaya S, Yokoyama H, Cherkasova E, McCoy JP, Hanada K, Mena O, Kurlander R, Tawab A, Srinivasan R, Lundqvist A, Malinzak E, Geller N, Lerman MI, Childs RW.

J Clin Invest. 2008 Mar;118(3):1099-109. doi: 10.1172/JCI34409. Erratum in: J Clin Invest. 2008 Apr;118(4):1584. Abdul, Tawab [corrected to Tawab, Abdul].

15.

Loss of PL6 protein expression in renal clear cell carcinomas and other VHL-deficient tumours.

Ivanova AV, Vortmeyer A, Ivanov SV, Nickerson ML, Maher ER, Lerman MI.

J Pathol. 2008 Jan;214(1):46-57.

PMID:
17973242
16.

Reduced expression of RASSF1A in esophageal and nasopharyngeal carcinomas significantly correlates with tumor stage.

Lo PH, Xie D, Chan KC, Xu FP, Kuzmin I, Lerman MI, Law S, Chua D, Sham J, Lung ML.

Cancer Lett. 2007 Nov 18;257(2):199-205. Epub 2007 Aug 27.

PMID:
17720308
17.

Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1.

Ivanova AV, Ivanov SV, Pascal V, Lumsden JM, Ward JM, Morris N, Tessarolo L, Anderson SK, Lerman MI.

J Pathol. 2007 Apr;211(5):591-601.

PMID:
17318811
18.

Hypermethylation of Ron proximal promoter associates with lack of full-length Ron and transcription of oncogenic short-Ron from an internal promoter.

Angeloni D, Danilkovitch-Miagkova A, Ivanova T, Braga E, Zabarovsky E, Lerman MI.

Oncogene. 2007 Jul 5;26(31):4499-512. Epub 2007 Feb 5.

PMID:
17297469
19.

Hyal2, where are you?

Miller AD, Vigdorovich V, Strong RK, Fernandes RJ, Lerman MI.

Osteoarthritis Cartilage. 2006 Dec;14(12):1315-7. Epub 2006 Sep 20. No abstract available.

20.

Functional studies of the chromosome 3p21.3 candidate tumor suppressor gene BLU/ZMYND10 in nasopharyngeal carcinoma.

Yau WL, Lung HL, Zabarovsky ER, Lerman MI, Sham JS, Chua DT, Tsao SW, Stanbridge EJ, Lung ML.

Int J Cancer. 2006 Dec 15;119(12):2821-6.

21.

Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13.

Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI.

Oncogene. 2007 Feb 8;26(6):802-12. Epub 2006 Jul 31.

PMID:
16878149
22.

Analysis of a new homozygous deletion in the tumor suppressor region at 3p12.3 reveals two novel intronic noncoding RNA genes.

Angeloni D, ter Elst A, Wei MH, van der Veen AY, Braga EA, Klimov EA, Timmer T, Korobeinikova L, Lerman MI, Buys CH.

Genes Chromosomes Cancer. 2006 Jul;45(7):676-91.

PMID:
16607615
23.
24.
25.

Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.

Yi Lo PH, Chung Leung AC, Xiong W, Law S, Duh FM, Lerman MI, Stanbridge EJ, Lung ML.

Cancer Lett. 2006 Mar 28;234(2):184-92.

PMID:
15885884
26.

Transcriptional regulator CTCF controls human interleukin 1 receptor-associated kinase 2 promoter.

Kuzmin I, Geil L, Gibson L, Cavinato T, Loukinov D, Lobanenkov V, Lerman MI.

J Mol Biol. 2005 Feb 18;346(2):411-22. Epub 2004 Dec 22.

PMID:
15670593
27.

Functional characterization of the candidate tumor suppressor gene NPRL2/G21 located in 3p21.3C.

Li J, Wang F, Haraldson K, Protopopov A, Duh FM, Geil L, Kuzmin I, Minna JD, Stanbridge E, Braga E, Kashuba VI, Klein G, Lerman MI, Zabarovsky ER.

Cancer Res. 2004 Sep 15;64(18):6438-43.

28.

Cerebellar ataxia, seizures, premature death, and cardiac abnormalities in mice with targeted disruption of the Cacna2d2 gene.

Ivanov SV, Ward JM, Tessarollo L, McAreavey D, Sachdev V, Fananapazir L, Banks MK, Morris N, Djurickovic D, Devor-Henneman DE, Wei MH, Alvord GW, Gao B, Richardson JA, Minna JD, Rogawski MA, Lerman MI.

Am J Pathol. 2004 Sep;165(3):1007-18.

29.

STRA13 interacts with STAT3 and modulates transcription of STAT3-dependent targets.

Ivanova AV, Ivanov SV, Zhang X, Ivanov VN, Timofeeva OA, Lerman MI.

J Mol Biol. 2004 Jul 16;340(4):641-53.

PMID:
15223310
30.

Inactivation of RASSF1C during in vivo tumor growth identifies it as a tumor suppressor gene.

Li J, Wang F, Protopopov A, Malyukova A, Kashuba V, Minna JD, Lerman MI, Klein G, Zabarovsky E.

Oncogene. 2004 Aug 5;23(35):5941-9.

PMID:
15208682
31.

Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.

Senchenko VN, Liu J, Loginov W, Bazov I, Angeloni D, Seryogin Y, Ermilova V, Kazubskaya T, Garkavtseva R, Zabarovska VI, Kashuba VI, Kisselev LL, Minna JD, Lerman MI, Klein G, Braga EA, Zabarovsky ER.

Oncogene. 2004 Jul 29;23(34):5719-28.

PMID:
15208675
33.

RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.

Kashuba VI, Li J, Wang F, Senchenko VN, Protopopov A, Malyukova A, Kutsenko AS, Kadyrova E, Zabarovska VI, Muravenko OV, Zelenin AV, Kisselev LL, Kuzmin I, Minna JD, Winberg G, Ernberg I, Braga E, Lerman MI, Klein G, Zabarovsky ER.

Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4906-11. Epub 2004 Mar 29.

34.

Characterization of a new SNP c767A/T (Arg222Trp) in the candidate TSG FUS2 on human chromosome 3p21.3: prevalence in Asian populations and analysis of association with nasopharyngeal cancer.

Duh FM, Fivash M, Moody M, Li Lung M, Guo X, Stanbridge E, Dean M, Voevoda M, Hu LF, Kashuba V, Zabarovsky ER, Qian CN, Godbole S, Tean Teh B, Lerman MI.

Mol Cell Probes. 2004 Feb;18(1):39-44.

PMID:
15036368
35.

The soluble sema domain of the RON receptor inhibits macrophage-stimulating protein-induced receptor activation.

Angeloni D, Danilkovitch-Miagkova A, Miagkov A, Leonard EJ, Lerman MI.

J Biol Chem. 2004 Jan 30;279(5):3726-32. Epub 2003 Nov 3.

36.

Epigenetic inactivation of RASSF1A in head and neck cancer.

Dong SM, Sun DI, Benoit NE, Kuzmin I, Lerman MI, Sidransky D.

Clin Cancer Res. 2003 Sep 1;9(10 Pt 1):3635-40.

38.

C to A single nucleotide polymorphism in intron 18 of the human MST1R (RON) gene that maps at 3p21.3.

Angeloni D, Duh FM, Moody M, Dean M, Zabarovsky ER, Sentchenko V, Braga E, Lerman MI.

Mol Cell Probes. 2003 Apr-Jun;17(2-3):55-7.

PMID:
12788025
39.

Deletion mapping using quantitative real-time PCR identifies two distinct 3p21.3 regions affected in most cervical carcinomas.

Senchenko V, Liu J, Braga E, Mazurenko N, Loginov W, Seryogin Y, Bazov I, Protopopov A, Kisseljov FL, Kashuba V, Lerman MI, Klein G, Zabarovsky ER.

Oncogene. 2003 May 15;22(19):2984-92.

PMID:
12771950
40.

Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.

Kuzmin I, Liu L, Dammann R, Geil L, Stanbridge EJ, Wilczynski SP, Lerman MI, Pfeifer GP.

Cancer Res. 2003 Apr 15;63(8):1888-93.

41.

Hyaluronidase 2 negatively regulates RON receptor tyrosine kinase and mediates transformation of epithelial cells by jaagsiekte sheep retrovirus.

Danilkovitch-Miagkova A, Duh FM, Kuzmin I, Angeloni D, Liu SL, Miller AD, Lerman MI.

Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4580-5. Epub 2003 Apr 3.

42.

Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma.

Liao SY, Ivanov S, Ivanova A, Ghosh S, Cote MA, Keefe K, Coca-Prados M, Stanbridge EJ, Lerman MI.

J Med Genet. 2003 Apr;40(4):257-61.

43.
44.

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.

Bui MH, Seligson D, Han KR, Pantuck AJ, Dorey FJ, Huang Y, Horvath S, Leibovich BC, Chopra S, Liao SY, Stanbridge E, Lerman MI, Palotie A, Figlin RA, Belldegrun AS.

Clin Cancer Res. 2003 Feb;9(2):802-11.

45.

An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.

Protopopov A, Kashuba V, Zabarovska VI, Muravenko OV, Lerman MI, Klein G, Zabarovsky ER.

Cancer Res. 2003 Jan 15;63(2):404-12.

46.

Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers.

Zabarovsky ER, Lerman MI, Minna JD.

Oncogene. 2002 Oct 7;21(45):6915-35. Review.

47.

Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.

Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.

Cancer Cell. 2002 Aug;2(2):157-64.

48.

Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor 1 alpha stabilization: a role for phosphatidylinositol 3'-kinase.

Kaluz S, Kaluzová M, Chrastina A, Olive PL, Pastoreková S, Pastorek J, Lerman MI, Stanbridge EJ.

Cancer Res. 2002 Aug 1;62(15):4469-77.

49.

NotI subtraction and NotI-specific microarrays to detect copy number and methylation changes in whole genomes.

Li J, Protopopov A, Wang F, Senchenko V, Petushkov V, Vorontsova O, Petrenko L, Zabarovska V, Muravenko O, Braga E, Kisselev L, Lerman MI, Kashuba V, Klein G, Ernberg I, Wahlestedt C, Zabarovsky ER.

Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10724-9. Epub 2002 Jul 29.

50.

Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: allelotyping and quantitative real-time PCR.

Braga E, Senchenko V, Bazov I, Loginov W, Liu J, Ermilova V, Kazubskaya T, Garkavtseva R, Mazurenko N, Kisseljov F, Lerman MI, Klein G, Kisselev L, Zabarovsky ER.

Int J Cancer. 2002 Aug 10;100(5):534-41.

Supplemental Content

Loading ...
Support Center